September 2016

Important New Products

• Descovy (emtricitabine (FTC) and tenofovir alafenamide (TAF) fumarate) contains ...(more)
• MS-2 Step (mifepristone, misoprostol (GyMiso)) contains mifepristone, a synthetic ...(more)

New Contraindications

• Cordilox SR (verapamil hydrochloride) is now contraindicated in the following situations. ...(more)
• Ikorel (nicorandil) is now also contraindicated in patients with severe hypotension or with ...(more)
• Solu-medrol (methylprednisolone sodium succinate) is now also contraindicated in the ...(more)
• Truvada (tenofovir disoproxil fumarate; emtricitabine) is now also contraindicated for ...(more)

New Indications

• Cosentyx (ecukinumab rch) is now also indicated for the treatment of adult patients with ...(more)
• Truvada (tenofovir disoproxil fumarate; emtricitabine) is now also indicated in combination ...(more)

New Presentation

• Dysport (botulinum toxin type a) is now available as 125 Ipsen units in vials of 1’s.

Active Ingredient Naming Changes

In this release, MIMS Australia will be including the following INNs (International Non-proprietary Names) as well as Australian Approved Names (AANs) as part of our push to support the Therapeutic Goods Administration (TGA) active ingredient name changes project.

MIMS will begin referring to these ingredients by their new names, however, users may continue to search by the old AANs if preferred.

Deleted Products

• Chemmart Alendronate
• Clavulin 125 Syrup
• Clavulin Duo 400 Suspension
• Cobasol

To contact MIMS editorial please email To enquire about purchasing a product please contact MIMS Customer service on 1800 800 629 or email For more information about MIMS, please see

Copyright © 2016 MIMS Australia Pty Ltd. All rights reserved.
Our mailing address is:
MIMS Australia, Level 2, 1 Chandos Street, St Leonards NSW 2065, Phone: 1800 800 629

Unsubscribe | Privacy